STAT

SEPTEMBER 20, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind. Read the rest…

285

285

STAT

APRIL 27, 2023

Editor’s Note: A livestream of the event will be embedded below at 1 p.m. Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers. Read the rest…

246

246

STAT

MAY 7, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. It took decades for scientists to come up with treatments that could slow the progression of Alzheimer’s disease. Now patients and physicians face a new challenge: actually getting the medicines to people who might benefit from them.

263

263

STAT

JANUARY 13, 2023

Editor’s note: A live stream of the event will be embedded below at 1 p.m. Relive the return to an in-person J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for next week. Read the rest…

246

246

STAT

JUNE 20, 2024

The outcome of the HELIOS-B study — expected at the end of June or early July — is an enormous stock-moving event for Alnylam Pharmaceuticals. STAT+ subscribers can sign up  here  to get it delivered every Thursday to their inbox.

316

316

STAT

MARCH 1, 2024

CommonSpirit Health is hosting an educational event this month featuring RaDonda Vaught, the Tennessee nurse who was criminally prosecuted for accidentally killing a patient by injecting the wrong medication.

Hospitals 299

Hospitals 299

STAT

APRIL 3, 2023

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter: When is “mid-year”? Is this a second-quarter event that should be included in this scorecard, or should it be pushed to the third quarter? This is not an existential question. Now, you know, just in case.

324

324

STAT

DECEMBER 14, 2022

Editor’s Note: A livestream of the event will be embedded below at 1 p.m.   Join  STAT for a discussion with industry experts on the most prominent work presented at this meeting and a look at what’s coming in hematology in the year ahead. Read the rest…

246

246

STAT

JUNE 21, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Pharmacy benefit managers are intermediaries that are supposed to negotiate lower drug costs. But does the system work for patients? And how can we fix it when it doesn’t? Read the rest…

Drug Pricing 246

Drug Pricing 246

The Pharmacist

OCTOBER 29, 2024

The barriers and opportunities involved in working collaboratively across different healthcare professions – including how pharmacists can work across the multidisciplinary team – have been explored during a House of Commons event.

117

117

STAT

SEPTEMBER 25, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m.   How do we ensure the population in a study best reflects the people who will get a medicine in the real world? Read the rest…

265

265

STAT

SEPTEMBER 25, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m.   How do we ensure the population in a study best reflects the people who will get a medicine in the real world? Read the rest…

259

259

STAT

MARCH 20, 2023

Editor’s note: A livestream on the event will be embedded below at 1 p.m. Physicians are burned out and overworked. Patients are having a difficult time seeing doctors quickly and understanding what specialists they can see. Read the rest…

231

231

STAT

APRIL 2, 2024

Here is STAT’s biotech scoreboard, our regular ledger of stock-moving biotech events, for the second quarter and middle of the year: Obesity catalysts, first. Danish drugmaker Zealand Pharma — yes, there’s another Danish drug maker in obesity — is developing a long-acting amylin analog called petrelintide.

283

283

Pharmafile

NOVEMBER 4, 2024

As a landmark event, FlyPharma Vienna 2024 has successfully wrapped, marking a pivotal gathering of industry professionals, expert speakers and delegates, from notable companies such as Sanofi, Takeda, Bayer, Amgen, Octapharma, Lufthansa, IATA, DHL, DoKaSch, Kühne + […] The post FlyPharma Vienna 2024: An Event to Remember!

59

59

STAT

DECEMBER 1, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

275

275

STAT

JULY 18, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Now that biosimilar versions of Humira are starting to arrive, what happens next? Will this finally prove the case that biosimilars can deliver on big health care savings? What key signals will indicate how biosimilars might be prescribed, or paid for?

Biosimilars 246

Biosimilars Drug Pricing 246

Putting Patients First Blog

AUGUST 23, 2024

Event Policies Please read the following Policies, Terms, and Conditions carefully as they are the National Health Council’s (NHC) registration policies for event attendees. When you register for the event, you agree to provide accurate and complete information. Hand sanitizer stations placed around the event’s meeting space.

Communication 52

Communication 52

STAT

JULY 2, 2024

H​​ere is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Late last month, Alnylam Pharmaceuticals reported positive, top-line results from its HELIOS-B clinical trial testing vutrisiran in an increasingly common heart disease called ATTR-CM.

284

284

STAT

JANUARY 2, 2024

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: In December, Vertex Pharmaceuticals announced results from a mid-stage clinical trial showing its experimental, non-opioid drug reduced pain in people with diabetes who have chronic pain.

Diabetes 278

Diabetes 278

PharmaVoice

OCTOBER 6, 2023

Trade shows and events focused on the industry’s hot-button topics, technologies and trends.

130

130

STAT

OCTOBER 2, 2023

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: The Food and Drug Administration’s decision in June to grant conditional approval to a gene therapy for Duchenne muscular dystrophy was a watershed moment for the treatment of the neuromuscular disease, and a big win for its maker, (..)

289

289

European Pharmaceutical Review

OCTOBER 2, 2023

CPHI Barcelona, the renowned global pharma event, is set to take centre stage from 24 to 26 October 2023 at Fira Barcelona Gran Via, Spain. Whether you’re seeking to forge relationships with thought leaders, trailblazers, or innovators, this event has it all.

Packaging 105

Packaging 105

Putting Patients First Blog

AUGUST 15, 2024

September Event Professionals Affinity Group Meeting Event Time: 9:00 - 10:30 a.m. ET Event Location: Virtual This meeting is for NHC members only. Please contact Racquel Codling , Director of Meetings & Events, for more information.

52

52

pharmaphorum

SEPTEMBER 19, 2024

Explore how the pharmaceutical industry is ensuring supply chain resilience to maintain consistency despite global events. Learn more about strategies and practices implemented to address challenges and ensure reliable delivery of pharmaceutical products.

97

97

pharmaphorum

OCTOBER 8, 2024

Collaboration is essential for the future of healthcare, and events play a pivotal role in fostering it. Learn how collaboration can drive innovation in healthcare through impactful events.

107

107

STAT

JUNE 9, 2023

Editor’s Note: A livestream of the event will be embedded below on Monday, June 12 at 1 p.m. ET Running a successful clinical trial is as much about execution as science, as companies and researchers must nail operational details from picking the right trial sites to ensuring patients remain in the study.

246

246

STAT

SEPTEMBER 30, 2022

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Arrowhead Pharmaceuticals and partner Takeda Pharmaceuticals are nearing the completion of a mid-stage, placebo-controlled clinical trial of an RNA-based drug called fazirsiran in patients with alpha-1 antitrypsin deficiency, or AATD, (..)

260

260

pharmaphorum

JANUARY 8, 2023

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday. The post JP Morgan 2023 – Pre event appeared first on. We’ll also wander over to the UC Davis Health Future & Health CEO Summit a little later this afternoon.

121

121

STAT

JANUARY 3, 2023

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Last year, a novel combination pill developed by Karuna Therapeutics reduced psychosis and related symptoms experienced by patients with schizophrenia, achieving the main goals of a late-stage clinical trial.

246

246

STAT

JULY 3, 2023

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: Novo Nordisk is conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health.

Hospitals 246

Hospitals 246

STAT

OCTOBER 12, 2022

Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. Like approaching asteroids, major biosimilars for Humira and other drugs are finally due to hit the market in 2023. Read the rest…

Biosimilars 246

Biosimilars 246

pharmaphorum

NOVEMBER 25, 2021

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. The changing events model. Before COVID, pharma events were mainly face-to-face.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

OCTOBER 11, 2024

Today, it proudly holds the mantle as Europe’s flagship partnering event. In 1994, BIO-Europe launched with the mission to drive biotech innovation and dealmaking forward through one-to-one partnering.

52

52

pharmacy mentor

MARCH 11, 2024

Managed by SF Media Ltd, this specialised pharmacy event planning and management company is deeply ingrained in the pharmacy industry, passionately creating events that exceed expectations and drive professional growth. Event Organisers: For those looking to host or list pharmacy-related events, pharmacyshows.co.uk

Community Pharmacies 52

Community Pharmacies 52

Viseven

JULY 25, 2024

In the second quarter of 2024, the Viseven team embarked on a global journey, traversing continents to attend and participate in the world’s most prominent pharmaceutical events. Reuters Pharma EU 2024 April was a whirlwind for us, kicking off with the Reuters event in Barcelona where we went all out.

Communication 52

Communication Drug Development 52

STAT

JULY 31, 2024

CHICAGO — “Buttery Biscuits & Hot Honey Gravy,” mushroom jerky, soy chicken nuggets, strawberry champagne donuts, plant-based frozen yogurt and buñuelos, white cheddar cheese puffs, chocolatey cookie dippers, egg-free Spanish cheesecake, plant-based chorizo-style empanadas … I was at the annual gathering of food (..)

361

361